This marks the first time a bispecific ADC has demonstrated a dual benefit in both PFS and OS within a phase 3 trial for TNBC. While standard chemotherapy options offer limited durability in the ...

Outpatient treatment enabled under FT819-102 autoimmune basket protocol with patients now treated with FT819 off-the-shelf CAR T-cell therapy as same-day hospital discharge ...

Pfizer Inc. (NYSE: PFE) today announced that the U.S. Food and Drug Administration (FDA) has granted full approval to BRAFTOVI® (encorafenib) in combination ...

Founded by IISc scientist Manjiri Bakre, OncoStem Diagnostics has developed CanAssist Breast (CAB), an AI-powered test to identify which early-stage breast cancer patients need chemotherapy and who ...

Kayla Esson, 22, from Buckie in Aberdeenshire, was alarmed after her face inflated and she started struggling to breathe ...

Three rounds of chemotherapy later, Topic completed his cancer treatment in Jan. 2026. Over the next six weeks, he'd be ...